Guidelines for assessing Pharmacokinetic Bias in Epidemiology

Melvin AndersenBlog

Melvin E. Andersen Biomarkers of exposure can be measured at lower and lower levels due to advances in analytical chemistry. Using these highly sensitive methods, some epidemiology studies report associations between plasma and urinary biomarkers and health outcomes at biomarker levels much below those associated with effects in animal studies. In some cases, these associations may arise from pharmacokinetic (PK) bias, i.e., a situation where a confounding …

ScitoVation Researcher Selected as Finalist

ScitoVationNews

Congratulations to Jake Reske! His abstract on transcriptomic predictive modeling for drug-induced cholestasis with ScitoVation was selected as a finalist for the Environmental Mutagenesis and Genomics Society Bioinformatics Challenge 2021.

Applications of PBPK Modeling in Pesticide Risk Assessment

ScitoVationNews, Webinars

Thanks to all who joined us on Tuesday, Mar. 30, for a special review of how PBPK modeling can be successfully applied to pesticide risk assessment, presented by Dr. Cecilia Tan, of the US EPA Office of Pesticide Programs. If you missed it, you may view the recording.

Development and Application of a Life Stage Physiologically based Pharmacokinetic (PBPK) Model to the Assessment of Internal Dose of Pyrethroids in Humans

Shiloh BarfieldNews

While insecticides are an essential to many food supply and public health concerns, they are sometimes associated with bioactivity and therefore raise questions about human and environmental health implications. Pyrethroids are insecticides used in household products, agricultural applications and mosquito control. In rat, juveniles were
more sensitive than adults to pyrethroid-driven health effects. The US Environmental Protection Agency (USEPA) raised questions about …Read more »